Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Malmo – page 49

1 356 clinical trials in Malmo, Sweden across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Malmo at a glance
1 356
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

1 356 trials in Malmo

Open in trial search

Dermatitis atopic

Not yet recruiting

Study on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Obesity+1

Not yet recruiting

A Phase III Study of Once‑Weekly Petrelintide to Evaluate Efficacy and Safety for Weight Loss in Adults with Overweight or Obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Petrelintide
  • Sponsor:F. Hoffmann-La Roche AG

Multiple sclerosis

Not yet recruiting

Long‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Breast cancer+2

Not yet recruiting

Gedatolisib with drug combination versus standard therapy as first‑line treatment for patients with advanced HR‑positive HER2‑negative breast cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Celcuity Inc.

Hereditary ataxia+1

Not yet recruiting

Long‑term safety of intrathecal VO659 in participants with Huntington’s disease, spinocerebellar ataxia type 1 or type 3

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:VO659
  • Sponsor:Vico Therapeutics B.V.

Study of Tozorakimab to Reduce Lung Inflammation and Promote Healing in Patients with COPD

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:University Of Leicester

Schizophrenia

Not yet recruiting

Phase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Pancreatic carcinoma+2

Not yet recruiting

Molecularly Tailored Therapy Versus Standard Care in Patients With Advanced Pancreatic Cancer Using Olaparib, Erlotinib, Crizotinib, Trametinib, Pemigatinib, Selpercatinib, Axitinib, Vismodegib, Pembrolizumab, Larotrectinib, Dabrafenib, Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan, Gemcitabine, Paclitaxel Albumin-Bound, and Calcium Folinate

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Region Hovedstaden

Ischaemic stroke

Not yet recruiting

A study to evaluate the use of tocilizumab in adults with acute ischemic stroke undergoing mechanical clot removal.

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Oslo Universitetssykehus HF

Renal transplant

Not yet recruiting

Study of the effect of dapagliflozin on the development of post-transplant diabetes in kidney transplant recipients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Odense University Hospital

Sjogren's syndrome

Not yet recruiting

A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

Hypertrophic cardiomyopathy

Not yet recruiting

Effect of oral mavacamten on left ventricular filling pressure in patients with hypertrophic cardiomyopathy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Region Hovedstaden

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Malmo

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on metastatic prostate cancer treatments and breakthrough therapies for colorectal cancer. Research includes studies of novel drug combinations and targeted therapies for breast cancer patients.

  • Advanced prostate cancer treatments
  • Colorectal cancer interventions
  • Breast cancer therapy optimization
02 Neurodegenerative Disorders

Comprehensive studies on Alzheimer's disease diagnostics and treatment, including innovative research on ALS therapies. Investigations utilize advanced imaging techniques and novel therapeutic approaches.

  • Early Alzheimer's intervention
  • ALS treatment development
  • Cognitive disorder diagnostics
03 Metabolic and Chronic Conditions

Trials examining treatments for obesity and type 2 diabetes, along with innovative approaches to managing chronic kidney disease. Research focuses on biomarker-targeted treatments and lifestyle interventions.

  • Weight management therapies
  • Diabetes treatment optimization
  • Kidney disease interventions
04 Infectious Diseases

Studies evaluating vaccines for respiratory syncytial virus, HPV, and Herpes Zoster. Research aims to prevent viral infections and improve vaccination strategies in various age groups.

  • Viral infection prevention
  • Vaccine effectiveness studies
  • Immunization programs
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.